Farkas K Christopher 4
4 · CURTISS WRIGHT CORP · Filed Mar 18, 2025
Insider Transaction Report
Form 4
Farkas K Christopher
Executive VP and CFO
Transactions
- Sale
Common Stock
2025-03-18$325.47/sh−922$300,083→ 14,033 total - Exercise/Conversion
Restricted Stock Unit
2025-03-17−2,243→ 10,894 totalExercise: $0.00From: 2025-03-16Exp: 2025-03-16→ Common Stock (2,243 underlying) - Exercise/Conversion
Common Stock
2025-03-17+2,243→ 14,955 total
Footnotes (5)
- [F1]These shares were acquired through a restricted stock unit ("RSU") grant under the Company's 2014 Omnibus Incentive Plan on March 17, 2022. The RSUs cliff vested in Issuer common stock after a three-year vesting period from the date of grant.
- [F2]No price on the date of issue. The restricted stock units were granted as an employee benefit transaction.
- [F3]Shares were sold in compliance with the Company's share ownership guidelines whereby the Reporting Person may sell a portion of the vesting award to cover any tax obligations associated with the vesting of the award. The Reporting Person is and remains in compliance with the share ownership guidelines.
- [F4]The price reported is the average selling price. The shares were sold in multiple transactions at prices ranging from $324.21 to $327.35, inclusive. The Reporting Person undertakes to provide the SEC, the issuer and any security holder full information regarding the number of shares sold at each separate price.
- [F5]Share total includes dividend credits earned on prior outstanding grants.